相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cautious Hope for Cannabidiol (CBD) in Rheumatology Care
Mary-Ann Fitzcharles et al.
ARTHRITIS CARE & RESEARCH (2023)
Virtual screening and in vitro experiments highlight cannabidiol as a drug-like phosphodiesterase 9 inhibitor
Giovanni Ribaudo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2023)
Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis
Nicholas Dopkins et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2022)
The role of glial cells in multiple sclerosis disease progression
Luke M. Healy et al.
NATURE REVIEWS NEUROLOGY (2022)
Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease
Meiyang Xi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection
Marcin Janecki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Cannabidiol Enhances Microglial Beta-Amyloid Peptide Phagocytosis and Clearance via Vanilloid Family Type 2 Channel Activation
Shaobin Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension
Anna Krzyzewska et al.
MOLECULES (2022)
Anti-inflammation and gingival wound healing activities of Cannabis sativa L. subsp. sativa (hemp) extract and cannabidiol: An in vitro study
Kheskanya Kongkadee et al.
ARCHIVES OF ORAL BIOLOGY (2022)
Differential Effects of D9 Tetrahydrocannabinol (THC)- and Cannabidiol (CBD)-Based Cannabinoid Treatments on Macrophage Immune Function In Vitro and on Gastrointestinal Inflammation in a Murine Model
Zhanna Yekhtin et al.
BIOMEDICINES (2022)
Inflammatory markers at baseline correlate with subsequent clinical response to quetiapine in patients with bipolar disorder
Marco Ferrari et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2022)
Alzheimer's Disease: From Immune Homeostasis to Neuroinflammatory Condition
Lucia Princiotta Cariddi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model
Elisa Landucci et al.
NEUROBIOLOGY OF DISEASE (2022)
Study protocol for a phase II, double-blind, randomised controlled trial of cannabidiol (CBD) compared with placebo for reduction of brain neuroinflammation in adults with chronic low back pain
Chelsea K. Pike et al.
BMJ OPEN (2022)
Cannabidiol modulates expression of type I IFN response genes and HIV infection in macrophages
Shallu Tomer et al.
FRONTIERS IN IMMUNOLOGY (2022)
Lymphocyte Count and Neutrophil-to-Lymphocyte Ratio Are Associated with Mild Cognitive Impairment in Parkinson's Disease: A Single-Center Longitudinal Study
Elena Contaldi et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Effect of Cannabidiol on Cyclooxygenase Type 1 and 2 Expression and Function in Human Neutrophils
Marco Cosentino et al.
CANNABIS AND CANNABINOID RESEARCH (2022)
CD4+T-CellTranscription Factors in IdiopathicREMSleep Behavior Disorder and Parkinson's Disease
Erika De Francesco et al.
MOVEMENT DISORDERS (2021)
Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review
Alessia Furgiuele et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2021)
Expression of Transcription Factors in CD4+T Cells as Potential Biomarkers of Motor Complications in Parkinson's Disease
Elena Contaldi et al.
JOURNAL OF PARKINSONS DISEASE (2021)
Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review
Md Sultan Mahmud et al.
MOLECULES (2021)
Cannabidiol selectively modulates interleukin (IL)-1β and IL-6 production in toll-like receptor activated human peripheral blood monocytes
Sera Sermet et al.
TOXICOLOGY (2021)
Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment
Claudia Taborda Gomez et al.
PHARMACEUTICALS (2021)
Blood-Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration
Alla B. Salmina et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Studies of involvement of G-protein coupled receptor-3 in cannabidiol effects on inflammatory responses of mouse primary astrocytes and microglia
Jun Wu et al.
PLOS ONE (2021)
Wheels Within Wheels: Theory and Practice of Epileptic Networks
Kathryn A. Davis et al.
EPILEPSY CURRENTS (2021)
Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease
Claudio Giuliano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Inflammation, anxiety, and stress in bipolar disorder and borderline personality disorder: A narrative review
L. F. Saccaro et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)
The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination
Carmen Lorena Robaina Cabrera et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2021)
Multi-target Natural and Nature-Inspired Compounds against Neurodegeneration: A Focus on Dual Cholinesterase and Phosphodiesterase Inhibitors
Giovanni Ribaudo et al.
APPLIED SCIENCES-BASEL (2021)
Oxidative Stress and Its Consequences in the Blood of Rats Irradiated with UV: Protective Effect of Cannabidiol
Michal Biernacki et al.
ANTIOXIDANTS (2021)
Cannabidiol-Driven Alterations to Inflammatory Protein Landscape of Lipopolysaccharide-Activated Macrophages In Vitro May be Mediated by Autophagy and Oxidative Stress
Daniel J. Yeisley et al.
CANNABIS AND CANNABINOID RESEARCH (2021)
The emerging role of Hippo signaling in neurodegeneration
Manas Ranjan Sahu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2020)
The temporal and causal relationship between inflammation and neurodegeneration in multiple sclerosis
Ron Milo et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Pharmacotherapy for the Treatment of Cannabis Use Disorder A Systematic Review
Karli K. Kondo et al.
ANNALS OF INTERNAL MEDICINE (2020)
Immune response to stress induction as a predictor of cognitive-behavioral therapy outcomes in adolescent mood disorders: A pilot study
Jennifer G. Pearlstein et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2020)
Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats
Ewa Kozela et al.
MOLECULAR NEUROBIOLOGY (2020)
Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?
Michele Tufano et al.
MOLECULES (2020)
Neutrophils as regulators of cardiovascular inflammation
Carlos Silvestre-Roig et al.
NATURE REVIEWS CARDIOLOGY (2020)
Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Sinemyiz Atalay et al.
ANTIOXIDANTS (2020)
Mast Cells in Inflammation and Disease: Recent Progress and Ongoing Concerns
Stephen J. Galli et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases
Melanie Kienzl et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2020)
Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes
Viviana di Giacomo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Inhibitory Effect of Cannabidiol on the Activation of NLRP3 Inflammasome Is Associated with Its Modulation of the P2X7 Receptor in Human Monocytes
Chang Liu et al.
JOURNAL OF NATURAL PRODUCTS (2020)
B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers
Jamie van Langelaar et al.
FRONTIERS IN IMMUNOLOGY (2020)
An Attempt to Polarize Human Neutrophils Toward N1 and N2 Phenotypes in vitro
Mareike Ohms et al.
FRONTIERS IN IMMUNOLOGY (2020)
Expansion of Neutrophils and Classical and Nonclassical Monocytes as a Hallmark in Relapsing-Remitting Multiple Sclerosis
David Haschka et al.
FRONTIERS IN IMMUNOLOGY (2020)
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications
Emilio Perucca et al.
CNS DRUGS (2020)
Relationship between circulating CD4+T lymphocytes and cognitive impairment in patients with Parkinson's disease
Luca Magistrelli et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Targeting neutrophils in asthma: A therapeutic opportunity?
Joyceline De Volder et al.
BIOCHEMICAL PHARMACOLOGY (2020)
TRPV1 genetic polymorphisms and risk of COPD or COPD combined with PH in the Han Chinese population
Mingmei Xiong et al.
CELL CYCLE (2020)
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Patricia Alves et al.
PHARMACOLOGICAL RESEARCH (2020)
Cannabidiol Modifies the Formation of NETs in Neutrophils of Psoriatic Patients
Piotr Wojcik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Essential Medicinal Chemistry of Cannabidiol (CBD)
Kathryn M. Nelson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action
Jakub Mlost et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders
Sudhir M. Baswan et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2020)
Cannabidiol for Viral Diseases: Hype or Hope?
Alex Mabou Tagne et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disease
Chrysoula Marogianni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Investigation of Catechol-O-Methyltransferase and Cannabinoid Receptor 2 gene variants in tobacco use disorder or tobacco use disorder and schizophrenia comorbidity
Sacide Pehlivan et al.
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY (2020)
Pathophysiology of Crohn's disease inflammation and recurrence
L. Petagna et al.
BIOLOGY DIRECT (2020)
Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia
Amnon A. Berger et al.
BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY (2020)
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential
C. Michael White
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Do Th17 Lymphocytes and IL-17 Contribute to Parkinson's Disease? A Systematic Review of Available Evidence
Elisa Storelli et al.
FRONTIERS IN NEUROLOGY (2019)
Astrocytes in multiple sclerosis and experimental autoimmune encephalomyelitis: Star-shaped cells illuminating the darkness of CNS autoimmunity
Wenjing Yi et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Joints for joints: cannabinoids in the treatment of rheumatoid arthritis
Torsten Lowin et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
A Novel Standardized Cannabis sativa L. Extract and Its Constituent Cannabidiol Inhibit Human Polymorphonuclear Leukocyte Functions
Alex Mabou Tagne et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high-fat high cholesterol diet via regulating NF-κB and NLRP3 inflammasome pathway
Yuanling Huang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
Smriti Subedi et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Cannabinoids and inflammation: implications for people living with HIV
Cecilia T. Costiniuk et al.
AIDS (2019)
The IL-1 family of cytokines and receptors in rheumatic diseases
Charles Anthony Dinarello
NATURE REVIEWS RHEUMATOLOGY (2019)
Cannabidiol (CBD) use in psychiatric disorders: A systematic review
Stefania Bonaccorso et al.
NEUROTOXICOLOGY (2019)
Cannabidiol Regulates the Expression of Keratinocyte Proteins Involved in the Inflammation Process through Transcriptional Regulation
Anna Jastrzab et al.
CELLS (2019)
Chronic exercise modulates the cellular immunity and its cannabinoid receptors expression
Salvador Valencia-Sanchez et al.
PLOS ONE (2019)
Complement activation and regulation in rheumatic disease
Douwe J. Dijkstra et al.
SEMINARS IN IMMUNOLOGY (2019)
Cannabidiol differentially regulates basal and LPS-induced inflammatory responses in macrophages, lung epithelial cells, and fibroblasts
Thivanka Muthumalage et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
Cannabidiol: A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes
Jeffrey W. Chen et al.
ANNALS OF PHARMACOTHERAPY (2019)
Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson's Disease
Natasa Kustrimovic et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Acetylsalicylic acid and its metabolite gentisic acid may act as adjunctive agents in the treatment of psychiatric disorders
Meric A. Altinoz et al.
BEHAVIOURAL PHARMACOLOGY (2019)
Osteoarthritis year in review 2018: clinical
L. A. Mandl
OSTEOARTHRITIS AND CARTILAGE (2019)
An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia
Tine van de Donk et al.
PAIN (2019)
Correlation of PMN elastase and PMN elastase-to-neutrophil ratio with disease activity in patients with myositis
Siyu Wu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Cannabinoid Ligands Targeting TRP Channels
Chante Muller et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)
Phillip Good et al.
BMC PALLIATIVE CARE (2019)
An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine
Ivan Urits et al.
PAIN AND THERAPY (2019)
Electroacupuncture inhibits mast cell degranulation via cannabinoid CB2 receptors in a rat model of allergic contact dermatitis
Zhigang Wang et al.
ACUPUNCTURE IN MEDICINE (2019)
The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews
Suzanne Nielsen et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2018)
Cannabinoids and glial cells: possible mechanism to understand schizophrenia
Valeria de Almeida et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2018)
Cannabidiol induced apoptosis in human monocytes through mitochondrial permeability transition pore-mediated ROS production
Hsin-Ying Wu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+Th1/Th2/T17 and Treg in drug-naive and drugtreated patients
Natasa Kustrimovic et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Systematic review and meta-analysis of cannabinoids in palliative medicine
Martin Muecke et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Natural killer cells in inflammation and autoimmunity
Beatrice Zitti et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2018)
Eosinophils: Friends or Foes?
Michael J. Chusid
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Lesley Taylor et al.
CNS DRUGS (2018)
Medical Use of Cannabinoids
Ana Isabel Fraguas-Sanchez et al.
DRUGS (2018)
Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial
Kerri A. Schoedel et al.
EPILEPSY & BEHAVIOR (2018)
Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer
Federica Pellati et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Natural killer cells and other innate lymphoid cells in cancer
Laura Chiossone et al.
NATURE REVIEWS IMMUNOLOGY (2018)
The Cannabinoids Delta(THC)-T-8, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation
Dinesh Thapa et al.
CANNABIS AND CANNABINOID RESEARCH (2018)
Impact of cannabidiol treatment on regulatory T-17 cells and neutrophil polarization in acute kidney injury
Babak Baban et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
The Logistics of Myelin Biogenesis in the Central Nervous System
Nicolas Snaidero et al.
GLIA (2017)
Dopaminergic Regulation of Innate Immunity: a Review
Monica Pinoli et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2017)
Anti-inflammatory treatments for mood disorders: Systematic review and meta-analysis
Muhammad I. Husain et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
T cells from patients with Parkinson's disease recognize α-synuclein peptides
David Sulzer et al.
NATURE (2017)
Microglial Interferon Signaling and White Matter
Ashley McDonough et al.
NEUROCHEMICAL RESEARCH (2017)
Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis
Holly T. Philpott et al.
PAIN (2017)
Production of IL-8, VEGF and Elastase by Circulating and Intraplaque Neutrophils in Patients with Carotid Atherosclerosis (Vol 10, e0124565, 2015)
Franca Marino et al.
PLOS ONE (2017)
Mitochondrial functions of THP-1 monocytes following the exposure to selected natural compounds
Nadin Schultze et al.
TOXICOLOGY (2017)
Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies
C. F. M. G. van Kesteren et al.
TRANSLATIONAL PSYCHIATRY (2017)
Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy
Kevin A. Clayton et al.
FRONTIERS IN NEUROSCIENCE (2017)
Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury
Yuping Wang et al.
SCIENTIFIC REPORTS (2017)
CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma
M. E. Ferrini et al.
ALLERGY (2017)
Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers
Shanna Babalonis et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen-induced pulmonary inflammation in mice
R. B. Frei et al.
ALLERGY (2016)
Therapeutic Potential of Cannabinoids in Psychosis
F. Markus Leweke et al.
BIOLOGICAL PSYCHIATRY (2016)
Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPAR and 5-HT1A receptors
William H. Hind et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Review of pulmonary adverse effects of infliximab therapy in Crohn's disease
Dhiren Patel et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Effects of EPHX1 and CYP3A4*22 genetic polymorphisms on carbamazepine metabolism and drug response among Tunisian epileptic patients
Chahra Chbili et al.
JOURNAL OF NEUROGENETICS (2016)
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence
Mellar P. Davis
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease
Ester Aso et al.
FRONTIERS IN NEUROSCIENCE (2016)
Dopaminergic Receptors on CD4+T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease
Natasa Kustrimovic et al.
SCIENTIFIC REPORTS (2016)
Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy
Istvan Ujvary et al.
CANNABIS AND CANNABINOID RESEARCH (2016)
Macrophage polarization in pathology
Antonio Sica et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Neutrophil-related factors as biomarkers in EAE and MS
Julie M. Rumble et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function
Guy A. Cabral et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
The Role of Innate Immunity in Osteoarthritis: When Our First Line of Defense Goes On the Offensive
Eric W. Orlowsky et al.
JOURNAL OF RHEUMATOLOGY (2015)
Cannabidiol as a Potential Treatment for Anxiety Disorders
Esther M. Blessing et al.
NEUROTHERAPEUTICS (2015)
Molecular Targets of Cannabidiol in Neurological Disorders
Clementino Ibeas Bih et al.
NEUROTHERAPEUTICS (2015)
Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index
Liina Haring et al.
SCHIZOPHRENIA RESEARCH (2015)
Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy
Hans-Gert Bernstein et al.
SCHIZOPHRENIA RESEARCH (2015)
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures
Natalia Malek et al.
NEURAL PLASTICITY (2015)
The Effect of Phytocannabinoids on Airway Hyper-Responsiveness, Airway Inflammation, and Cough
Raj Makwana et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
Golam M. Khandaker et al.
LANCET PSYCHIATRY (2015)
Microglia Development and Function
Debasis Nayak et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Tumor necrosis factor inhibitors - state of knowledge
Krzysztof Lis et al.
ARCHIVES OF MEDICAL SCIENCE (2014)
Simvastatin down-regulates the production of Interleukin-8 by neutrophil leukocytes from dyslipidemic patients
Franca Marino et al.
BMC CARDIOVASCULAR DISORDERS (2014)
Cannabidiol enhances microglial phagocytosis via transient receptor potential ( TRP) channel activation
Samia Hassan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
Stephen M. Stout et al.
DRUG METABOLISM REVIEWS (2014)
NK cells gain higher IFN-γ competence during terminal differentiation
Merlin Luetke-Eversloh et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Leukocyte Migration into Inflamed Tissues
Sussan Nourshargh et al.
IMMUNITY (2014)
Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
M. H. N. Chagas et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)
Protective Effects of Cannabidiol Against Hippocampal Cell Death and Cognitive Impairment Induced by Bilateral Common Carotid Artery Occlusion in Mice
Angelica Pupin Schiavon et al.
NEUROTOXICITY RESEARCH (2014)
Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: Comparison with schizophrenia
A. Carlo Altamura et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2014)
Eosinophils Are Important for Protection, Immunoregulation and Pathology during Infection with Nematode Microfilariae
Emma T. Cadman et al.
PLOS PATHOGENS (2014)
Pharmacology of Hallucinations: Several Mechanisms for One Single Symptom?
Benjamin Rolland et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Innate immune activation in neurodegenerative disease
Michael T. Heneka et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Cannabidiol Improves Vasorelaxation in Zucker Diabetic Fatty Rats through Cyclooxygenase Activation
Amanda J. Wheal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Immunity, atherosclerosis and cardiovascular disease
Johan Frostegard
BMC MEDICINE (2013)
The Role of Polymorphonuclear Leukocyte Trafficking in the Perpetuation of Inflammation During Inflammatory Bowel Disease
Jennifer C. Brazil et al.
INFLAMMATORY BOWEL DISEASES (2013)
Macrophage biology in development, homeostasis and disease
Thomas A. Wynn et al.
NATURE (2013)
Overview of Complement Activation and Regulation
Marina Noris et al.
SEMINARS IN NEPHROLOGY (2013)
Neutrophil recruitment and function in health and inflammation
Elzbieta Kolaczkowska et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Eosinophils: changing perspectives in health and disease
Helene F. Rosenberg et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Neutrophil Function: From Mechanisms to Disease
Borko Amulic et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor
Alison Ribeiro et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Cannabidiol-induced apoptosis in murine microglial cells through lipid raft
Hsin-Ying Wu et al.
GLIA (2012)
Neutrophils in multiple sclerosis are characterized by a primed phenotype
Matthias Naegele et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury
Peter S. Amenta et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis
S. A. Hiles et al.
PSYCHOLOGICAL MEDICINE (2012)
Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress
M. Mecha et al.
CELL DEATH & DISEASE (2012)
Newly appreciated roles for basophils in allergy and protective immunity
H. Karasuyama et al.
ALLERGY (2011)
Etanercept An Overview of Dermatologic Adverse Events
Lidian L. A. Lecluse et al.
ARCHIVES OF DERMATOLOGY (2011)
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death
Partha Mukhopadhyay et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
Ana Maria Martin-Moreno et al.
MOLECULAR PHARMACOLOGY (2011)
Transient Receptor Potential Channel Polymorphisms Are Associated with the Somatosensory Function in Neuropathic Pain Patients
Andreas Binder et al.
PLOS ONE (2011)
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis
Daniele De Filippis et al.
PLOS ONE (2011)
Cannabidiol Reduces Ab- Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
Giuseppe Esposito et al.
PLOS ONE (2011)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
Astrocytes: biology and pathology
Michael V. Sofroniew et al.
ACTA NEUROPATHOLOGICA (2010)
Role of polymorphonuclear neutrophils in atherosclerosis: Current state and future perspectives
Roberta Baetta et al.
ATHEROSCLEROSIS (2010)
Mechanisms Underlying Inflammation in Neurodegeneration
Christopher K. Glass et al.
CELL (2010)
Cannabidiol Induces Intracellular Calcium Elevation and Cytotoxicity in Oligodendrocytes
Susana Mato et al.
GLIA (2010)
Interaction between cytokines, cannabinoids and the nervous system
Lucie Jean-Gilles et al.
IMMUNOBIOLOGY (2010)
Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells
Ewa Kozela et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Autophagy: cellular and molecular mechanisms
Danielle Glick et al.
JOURNAL OF PATHOLOGY (2010)
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2 and adenosine receptors
A. Castillo et al.
NEUROBIOLOGY OF DISEASE (2010)
Cannabidiol induced a contrasting pro-apoptotic effect between freshly isolated and precultured human monocytes
Hsin-Ying Wu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Immune and Inflammatory Mechanisms of Atherosclerosis
Elena Galkina et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Time-dependent vascular actions of cannabidiol in the rat aorta
Saoirse E. O'Sullivan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats
Marcelo H. Napimoga et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder: A Systematic Review of the Literature
Benjamin I. Goldstein et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Cannabidiol for the treatment of psychosis in Parkinson's disease
A. W. Zuardi et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
SYSTEMIC INFECTION AND INFLAMMATION IN ACUTE CNS INJURY AND CHRONIC NEURODEGENERATION: UNDERLYING MECHANISMS
J. L. Teeling et al.
NEUROSCIENCE (2009)
Functional Characterization of Low-Prevalence Missense Polymorphisms in the UDP-Glucuronosyltransferase 1A9 Gene
Kristine C. Olson et al.
DRUG METABOLISM AND DISPOSITION (2009)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Cannabinoid receptors in acute and chronic complications of atherosclerosis
F. Mach et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up
Luigina Guasti et al.
EUROPEAN HEART JOURNAL (2008)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism
Kazuhide Hayakawa et al.
NEUROPHARMACOLOGY (2008)
Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids:: Evidence for a site distinct from CB1 and CB2
Douglas McHugh et al.
MOLECULAR PHARMACOLOGY (2008)
Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain
Mellar P. Davis
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells
Elda Del Giudice et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Angiotensin II type I receptor expression in polymorphonuclear leukocytes from high-risk subjects: Changes after treatment with simvastatin
Franca Marino et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function
Lea Fialkow et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Astrocytes are active players in cerebral innate immunity
Cinthia Farina et al.
TRENDS IN IMMUNOLOGY (2007)
Simvastatin treatment modifies polymorphonuclear leukocyte function in high-risk individuals: a longitudinal study
Luigina Guasti et al.
JOURNAL OF HYPERTENSION (2006)
Neutrophils and immunity: challenges and opportunities
C Nathan
NATURE REVIEWS IMMUNOLOGY (2006)
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors
M Kathmann et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2006)
Searching for polymorphisms that affect gene expression and mRNA processing: Example ABCB1 (MDR1)
Danxin Wang et al.
AAPS JOURNAL (2006)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro
P Sacerdote et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells
S Kishimoto et al.
JOURNAL OF BIOCHEMISTRY (2005)
Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-κB-dependent apoptosis:: Novel role for endogenous and exogenous cannabinoids in immunoregulation
Y Do et al.
JOURNAL OF IMMUNOLOGY (2004)
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson's disease. The effect of dopaminergic treatment
F Blandini et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament
HS Kim et al.
PAIN (2004)
A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activity
H Yamanaka et al.
PHARMACOGENETICS (2004)
Immunologic variables in acute mania of bipolar disorder
HC Liu et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
J Zajicek et al.
LANCET (2003)
Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality - The Framingham Heart Study
TJ Wang et al.
CIRCULATION (2003)
Nonpsychotropic cannabinoid receptors regulate microglial cell migration
L Walter et al.
JOURNAL OF NEUROSCIENCE (2003)
Effects of delta-9-tetrahydrocannabinol on human immune function and host defense
MD Roth et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2002)
Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic Δ9-tetrahydrocannabinol administration
R Anikwue et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Presence and regulation of the endocannabinoid system in human dendritic cells
I Matias et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
CF Lucchinetti et al.
BRAIN (2002)
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
AM Malfait et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60 -: Possible involvement of the CB2 receptor in cell differentiation
JM Derocq et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
